Upcoming Nigerian Rapper, Cameey Dies Of Liver Cancer

Updated Friday 23 August 2019 6:17
Upcoming Nigerian Rapper, Cameey Dies Of Liver Cancer
Joel Essoumam, otherwise known as Cameey has passed away after a long battle with Hepatitis B, which later developed into Liver cancer.

Did you know? You can comment on this post! Just scroll down

the fast rising rapper was said to have been battling hepatitis B which later degenerated into cancer of the liver. He died on Thursday afternoon, August 22.

Although, many Nigerian celebrities had earlier posted on their social media for fans to help him raise $100.000 which is almost 30 millionaire naira demanded for his treatment.

His management broke the news of his death on his Instagram page, stating that all donations should end.

Fans of the rapper have trooped to his comment section to mourn him and express their schock as he will be greatly missed.

Enjoy amazing and interactive content on DoroTV. We bring you all the gist, movies, music and news that will make you enjoy staring at your phone and computer screen when you are bored or when you want some action.

Always remember to check us out and check other amazing news, videos to download and watch, articles and music to download and play on our platform. We will always make it worthwhile for you.

This is a promise. Thank you for coming to DoroTV

Article Posted 5 Months ago. You can post your own articles and it will be published for free. No Registration is required! But we review before publishing! Click here to get started

Love This? Share It!

One Favour Please! Subscribe To Our YouTube Channel!


Like us on Facebook, Follow on Twitter

React and Comment

Click Here To Hide More Posts Like This
Watch and Download Free Mobile Movies, Read entertainment news and reports, Download music and Upload your own For FREE. Submit Your Content to be published for you FREE! We thrive on user-submitted content! But we moderate!

We use cookies to serve you better. We have to let you know this in accordance with EU laws. You accept our terms and conditions by using this platform. Please Click on the OK button below to hide this message